Use the keywords feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#21
REVIEW
Brian Bridal Løgstrup
There is a significant increase in risk of heart failure in several rheumatic diseases. Common cardiovascular risk factors and inflammatory processes, present in both rheumatic diseases and heart failure, are contributing to this increase. The opportunities for using immune-based strategies to fight development of heart failure in rheumatic diseases are evolving. The diversity of inflammation calls for a tailored characterization of inflammation, enabling differentiation of inflammation and subsequent introduction of precision medicine using target-specific strategies and immunomodulatory therapy...
February 2023: Rheumatic Diseases Clinics of North America
#22
Rudolf Puchner
No abstract text is available yet for this article.
2022: Rheuma Plus
#23
(no author information available yet)
No abstract text is available yet for this article.
2022: Rheuma Plus
#24
(no author information available yet)
No abstract text is available yet for this article.
2022: Rheuma Plus
#25
EDITORIAL
Elisabeth Märker-Hermann
No abstract text is available yet for this article.
November 8, 2022: Zeitschrift Für Rheumatologie
#26
JOURNAL ARTICLE
Rosario Foti, Giorgia Giuffrida, Alice Ramondetta, Giorgio Amato, Elisa Visalli, Riccardo Foti, Francesco De Lucia, Ylenia Dal Bosco, Rocco De Pasquale
INTRODUCTION: Early psoriatic arthritis (PsA) diagnosis is critical to prescribe timely treatment to prevent the irreversible joint damage and the many other problems that patients with PsA experience. This retrospective study aimed to highlight the benefits of a Rheuma-Derma Clinic focused on the early diagnosis and prompt treatment of PsA with a shared approach among Italian psoriasis patients. Diagnosing PsA early is the main goal to reduce joint damage and disability in the patients affected...
November 4, 2022: Dermatology and Therapy
#27
JOURNAL ARTICLE
Savia de Souza, Eva C Johansson, Susanne Karlfeldt, Karim Raza, Ruth Williams
BACKGROUND: Rheuma Tolerance for Cure (RTCure) is a five-year international collaboration between academia, industry and patients/members of the public. It focuses on developing approaches to predict the onset of rheumatoid arthritis (RA) and designing clinical trials to reduce the risk of disease development through immune-tolerising and other treatments. We conducted a mid-term evaluation of patient and public involvement (PPI) within the project. METHODS: Two surveys on PPI were co-designed by the PPI Coordinator, Patient/Public Research Partners (PRPs) and a researcher...
October 22, 2022: BMC rheumatology
#28
EDITORIAL
Andreas Radbruch, Reinhold E Schmidt
No abstract text is available yet for this article.
October 2022: Zeitschrift Für Rheumatologie
#29
(no author information available yet)
No abstract text is available yet for this article.
2022: Rheuma Plus
#30
(no author information available yet)
No abstract text is available yet for this article.
2022: Rheuma Plus
#31
Christian Huemer
No abstract text is available yet for this article.
2022: Rheuma Plus
#32
(no author information available yet)
No abstract text is available yet for this article.
2022: Rheuma Plus
#33
(no author information available yet)
No abstract text is available yet for this article.
2022: Rheuma Plus
#34
JOURNAL ARTICLE
Elke Oberhofer
No abstract text is available yet for this article.
September 2022: MMW Fortschritte der Medizin
#35
JOURNAL ARTICLE
Elke Oberhofer
No abstract text is available yet for this article.
September 2022: MMW Fortschritte der Medizin
#36
JOURNAL ARTICLE
Petra Staubach, Katrin Veelen, Sebastian Zimmer, Anna Sohn, Berenice M Lang, Adriane Peveling-Oberhag, Stephan Grabbe, Wiebke Kaluza-Schilling, Andreas Schwarting, Joanna Wegner
BACKGROUND: Treatment of patients with systemic autoimmune and/or autoinflammatory diseases (AI/AInf) often requires multidisciplinary collaboration of various medical specialties. OBJECTIVES: We evaluated whether the establishment of a multidisciplinary board, which we termed rheuma board (RB), can contribute to optimization of care for patients with psoriatic arthritis (PsA) or other AI/AInf. MATERIALS AND METHODS: A total of 272 patients were included in the study...
September 7, 2022: Dermatologie (Heidelb)
#37
Rudolf Puchner
No abstract text is available yet for this article.
2022: Rheuma Plus
#38
REVIEW
Max Löhning, Ping Shen, Maria Dzamukova, Nayar Durán-Hernández, Jay Roodselaar, Anja E Hauser, Alexander Fiedler, Raluca A Niesner, Timo Gaber, Frank Buttgereit
Rheumatoid arthritis and osteoarthritis are two related chronic diseases of the musculoskeletal system which are particularly pronounced in the region of joints and bones. Their pathogeneses are associated with chronic inflammation, which can disrupt homeostasis in bones and articular cartilage. Degradation products deriving from articular cartilage can contribute to the exacerbation of inflammation in the joint region. Mechanical stimuli and blood vessels also play a central role in both the regulation of bone growth as well as in the regeneration of bone tissue...
April 12, 2022: Zeitschrift Für Rheumatologie
#39
(no author information available yet)
No abstract text is available yet for this article.
2022: Rheuma Plus
#40
(no author information available yet)
No abstract text is available yet for this article.
2022: Rheuma Plus
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
